Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19
2021-10-07
0:00
17:22
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
Fler avsnitt från "Coronavirus (COVID-19) Q&A"
Missa inte ett avsnitt av “Coronavirus (COVID-19) Q&A” och prenumerera på det i GetPodcast-appen.